ATRA

Atara Biotherapeutics
ATRA

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$47.45M
EV
$75.55M
Shares Outstanding
5.96M
Beta
0.19

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$16.00
P/E 2025E
3.51x
P/Revenue 2025E
0.38x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Atara Biotherapeutics, Inc.

gainify
ATRA

Atara Biotherapeutics, Inc.

ATRA

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases in the United States and the United Kingdom. Its lead product includes Tab-cel (tabelecleucel), a T-cell imm...

Sector

Healthcare

Industry

Biotechnology

CEO

Nguyen, Anhco

Employees

89

IPO Date

2014-10-16

Headquarters

2380 Conejo Spectrum Street, Suite 200, Thousand Oaks, California, 91320, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.